Back to results
US 2026/0085303 A1Published application
Cell wall hydrolases targeting c. acnes
AssigneeTopaz Biosciences, Inc.
InventorsJennifer SHOCK, Maritza MILLER, Oliver LIU, Teresa SHOCK
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to novel cell wall binding domains, enzymatically active domains, and chimeric cell wall hydrolases with anti-Cutibacterium acnes activity. The disclosure also relates to compositions comprising these, and uses thereof in the treatment of conditions associated with Cutibacterium acnes.
Claims28
A chimeric cell wall hydrolase (CWH) comprising an amino acid sequence having at least 90% sequence identity with SEQ ID NO:
- 53 or 106, wherein the chimeric CWH exhibits lytic activity against Cutibacterium acnes.
A method of treating a skin condition associated with Cutibacterium sp. comprising:
- applying a chimeric cell wall hydrolase (CWH) to the skin, wherein the CWH comprises an amino acid sequence having at least 90% sequence identity with SEQ ID NO:
- 53 or 106, wherein the chimeric CWH exhibits lytic activity against Cutibacterium sp.
Dependencies are inferred from the claim text.